Download Citation
Article Source:
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
Murakami K,
Kobayashi Y,
Uehara S,
Suzuki T,
Koide M,
et al.
(2017)
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.
PLOS ONE 12(7): e0181126.
https://doi.org/10.1371/journal.pone.0181126